Follow me on Twitter

I agree that content from Twitter will be displayed to me.

 

Head of Group
Director of Corporate Program

His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.

Contact Hours for Students

  • Wednesday 14:00 - 15:00
  • Room 2E405 (or online) 
  • only after appointment via E-Mail latest on Friday before
Publications

Showing entries 1 - 5 out of 307
Dvorak, V, Casiraghi, A, Colas, C, Koren, A, Tomek, T, Offensperger, F, Rukavina, A, Tin, G, Hahn, E, Dobner, S, Frommelt, F, Boeszoermenyi, A, Bernada, V, Hannich, JT, Ecker, GF, Winter, GE, Kubicek, S & Superti-Furga, G 2023, 'Paralog-dependent isogenic cell assay cascade generates highly selective SLC16A3 inhibitors', Cell Chemical Biology, vol. 30, no. 8, pp. 953-964.e9. https://doi.org/10.1016/j.chembiol.2023.06.029

Activities

P-glycoprotein - from inhibitor design to substrate prediction

Gerhard Ecker
44 Recontres Internationales de Chimie Therapeutique - Interfacing Chemical Biology, Natural Products and Drug Discovery
Conference, Talk or oral contribution
3.7.2008 - 3.7.2008

Prediction of substrate properties for ABC Drug-Transporter: The challenge continues

Gerhard Ecker
10th European Regional Meeting of the International-Society-for-the-Study-of-Xenobiotics
Conference, Talk or oral contribution
19.5.2008 - 19.5.2008

Classification models for hERG inhibitors by counter-propagation neural networks

Gerhard Ecker
235th American-Chemical-Society National Meeting (ACS 2018)
Conference, Talk or oral contribution
10.4.2008 - 10.4.2008

Pharmacoinformatic approaches to target P-glycoprotein - from inhibitor design to substrate prediction

Gerhard Ecker
235th American-Chemical-Society National Meeting (ACS 2018)
Conference, Talk or oral contribution
8.4.2008 - 8.4.2008

EUROPIN - A European Pharmacoinformatics Initative

Gerhard Ecker
II Innovative Medicines Initiative Information Day
Conference, Talk or oral contribution
11.3.2008 - 11.3.2008